Cell Growth Processes

"Cell Growth Processes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Processes required for CELL ENLARGEMENT and CELL PROLIFERATION.

Descriptor ID	D048708
MeSH Number(s)	G04.161 G07.345.249.410
Concept/Terms	Cell Growth Processes Cell Growth Processes Processes, Cell Growth

Below are MeSH descriptors whose meaning is more general than "Cell Growth Processes".

Biological Sciences [G]
Cell Physiological Phenomena [G04]
Cell Growth Processes [G04.161]
Physiological Phenomena [G07]
Growth and Development [G07.345]
Growth [G07.345.249]
Cell Growth Processes [G07.345.249.410]

Below are MeSH descriptors whose meaning is related to "Cell Growth Processes".

Below are MeSH descriptors whose meaning is more specific than "Cell Growth Processes".

Cell Growth Processes
Cell Enlargement
Cell Proliferation

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Cell Growth Processes" by people in this website by year, and whether "Cell Growth Processes" was a major or minor topic of these publications.

Bar chart showing 32 publications over 10 distinct years, with a maximum of 6 publications in 2005

To see the data from this visualization as text, click here.

Year	Minor Topic	Total
2005	6	6
2006	3	3
2007	3	3
2008	3	3
2009	4	4
2010	5	5
2011	2	2
2012	4	4
2013	1	1
2014	1	1

Below are the most recent publications written about "Cell Growth Processes" by people in Profiles.

Rath KS, Naidu SK, Lata P, Bid HK, Rivera BK, McCann GA, Tierney BJ, Elnaggar AC, Bravo V, Leone G, Houghton P, Hideg K, Kuppusamy P, Cohn DE, Selvendiran K. HO-3867, a safe STAT3 inhibitor, is selectively cytotoxic to ovarian cancer. Cancer Res. 2014 Apr 15; 74(8):2316-27.

View in: PubMed
Cen B, Mahajan S, Wang W, Kraft AS. Elevation of receptor tyrosine kinases by small molecule AKT inhibitors in prostate cancer is mediated by Pim-1. Cancer Res. 2013 Jun 01; 73(11):3402-11.

View in: PubMed
Piechocki MP, Wu GS, Jones RF, Jacob JB, Gibson H, Ethier SP, Abrams J, Yagita H, Venuprasad K, Wei WZ. Induction of proapoptotic antibodies to triple-negative breast cancer by vaccination with TRAIL death receptor DR5 DNA. Int J Cancer. 2012 Dec 01; 131(11):2562-72.

View in: PubMed
Warren GW, Romano MA, Kudrimoti MR, Randall ME, McGarry RC, Singh AK, Rangnekar VM. Nicotinic modulation of therapeutic response in vitro and in vivo. Int J Cancer. 2012 Dec 01; 131(11):2519-27.

View in: PubMed
Dioufa N, Farmaki E, Schally AV, Kiaris H, Vlahodimitropoulos D, Papavassiliou AG, Kittas C, Block NL, Chatzistamou I. Growth hormone-releasing hormone receptor splice variant 1 is frequently expressed in oral squamous cell carcinomas. Horm Cancer. 2012 Aug; 3(4):172-80.

View in: PubMed
Russo A, O'Bryan JP. Intersectin 1 is required for neuroblastoma tumorigenesis. Oncogene. 2012 Nov 15; 31(46):4828-34.

View in: PubMed
Gao P, Smith CD. Ablation of sphingosine kinase-2 inhibits tumor cell proliferation and migration. Mol Cancer Res. 2011 Nov; 9(11):1509-19.

View in: PubMed
Wang Y, Kellner J, Liu L, Zhou D. Inhibition of p38 mitogen-activated protein kinase promotes ex vivo hematopoietic stem cell expansion. Stem Cells Dev. 2011 Jul; 20(7):1143-52.

View in: PubMed
Song JH, Kandasamy K, Zemskova M, Lin YW, Kraft AS. The BH3 mimetic ABT-737 induces cancer cell senescence. Cancer Res. 2011 Jan 15; 71(2):506-15.

View in: PubMed
Jakymiw A, Patel RS, Deming N, Bhattacharyya I, Shah P, Lamont RJ, Stewart CM, Cohen DM, Chan EK. Overexpression of dicer as a result of reduced let-7 MicroRNA levels contributes to increased cell proliferation of oral cancer cells. Genes Chromosomes Cancer. 2010 Jun; 49(6):549-59.

View in: PubMed

People

Explore

Similar Concepts

Top Journals